{
    "clinical_study": {
        "@rank": "132868", 
        "arm_group": {
            "arm_group_label": "Normal", 
            "description": "Normal results from clinical exam and free of ocular pathology"
        }, 
        "brief_summary": {
            "textblock": "To collect data for a reference database."
        }, 
        "brief_title": "OCT Reference Database", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "Collection of multiple subjects to create a reference database."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects 18 years of age or older on the date of informed consent\n\n          2. Subjects able to understand the written informed consent and willing to participate\n             as evidenced by signing the informed consent\n\n          3. Subjects presenting at the site with normal eyes (eyes without pathology)\n\n          4. IOP \u2264 21 mmHg bilaterally\n\n          5. BCVA 20/40 or better (each eye)\n\n          6. Both eyes must be free of eye disease\n\n        Exclusion Criteria:\n\n          1. Subjects unable to tolerate ophthalmic imaging\n\n          2. Subject with ocular media not sufficiently clear to obtain acceptable OCT images\n\n          3. HFA visual field (24-2 Sita Standard, white on white) result abnormal, defined as GHT\n             'Outside Normal Limits' and/or PSD < 5%\n\n          4. HFA visual field (24-2 Sita Standard, white on white) result unreliable (based on\n             manufacturer's recommendation), defined as fixation losses > 33% or false positives >\n             25%, or false negatives > 25%\n\n          5. Presence of any ocular pathology except for cataract\n\n          6. Previous ocular surgery or laser treatment, other than uncomplicated refractive\n             procedure or cataract surgery, performed within six months prior to study scanning\n\n          7. Narrow angle\n\n          8. History of leukemia, dementia or multiple sclerosis\n\n          9. Concomitant use of hydroxychloroquine and chloroquine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects that are Normal"
            }
        }, 
        "enrollment": {
            "#text": "389", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01986478", 
            "org_study_id": "DC-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85054"
                    }, 
                    "name": "Horizon Eye Specialist & Laser Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Livermore", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94550"
                    }, 
                    "name": "Valley Eyecare Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Keck School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pomona", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91716"
                    }, 
                    "name": "Western University of Health Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10036"
                    }, 
                    "name": "Stat University of New York College of Optometry"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study", 
        "overall_official": {
            "affiliation": "Senior Manager Product Planning Group", 
            "last_name": "Michael Sinai, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Retinal Thickness", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01986478"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Topcon Medical Systems, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Topcon Medical Systems, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}